2018年度

2018年度

(1) 原著

1) Coresh J**, Heerspink HJL**, Sang Y**, Matsushita K**, Arnlov J**, Astor BC**, Black C**, Brunskill NJ**, Carrero JJ**, Feldman HI**, Fox CS**, Inker LA**, Ishani A**, Ito S**, Jassal S**, Konta T, Polkinghorne K**, Romundstad S**, Solbu MD**, Stempniewicz N**, Stengel B**, Tonelli M**, Umesawa M**, Waikar SS**, Wen CP**, Wetzels JFM**, Woodward M**, Grams ME**, Kovesdy CP**, Levey AS**, Gansevoort RT**; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration: Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 2019; 7(2): 115-127 D

2) Namba H*, Sugano A*, Nishi K*, Murakami T*, Nishitsuka K*, Konta T, Ishizawa K*, Kayama T*, Yamashita H*: Age-related variations in corneal geometry and their association with astigmatism: The Yamagata Study (Funagata). Medicine (Baltimore). 2018; 97(43): e12894

3) Otaki Y*, Watanabe T*, Konta T, Watanabe M*, Fujimoto S**, Sato Y**, Asahi K**, Yamagata K**, Tsuruya K**, Narita I**, Kasahara M**, Shibagaki Y**, Iseki K**, Moriyama T**, Kondo M**, Watanabe T**: Effect of Hypertension on Aortic Artery Disease-Related Mortality - 3.8-Year Nationwide Community-Based Prospective Cohort Study. Circ J. 2018; 82(11): 2776-2782 B

4) Ogata E**, Asahi K**, Yamaguchi S**, Iseki K**, Sato H**, Moriyama T**, Yamagata K**, Tsuruya K**, Fujimoto S**, Narita I**, Konta T, Kondo M**, Shibagaki Y**, Kasahara M**, Watanabe T**, Shimabukuro M**: Low fasting plasma glucose level as a predictor of new-onset diabetes mellitus on a large cohort from a Japanese general population. Sci Rep. 2018; 8(1): 13927 B

5) Takahashi T*, Shishido T*, Watanabe K*, Sugai T*, Toshima T*, Kinoshita D*, Yokoyama M*, Tamura H*, Nishiyama S*, Takahashi H*, Arimoto T*, Miyamoto T*, Watanabe T*, Shibata Y*, Konta T, Ueno Y*, Kato T*, Kayama T*, Kubota I*, Watanabe M*: Ventricular wall stress and silent myocardial damage are associated with pulse pressure in the general population. J Clin Hypertens (Greenwich). 2018; 20(9): 1319-1326

6) Iseki K**, Konta T, Asahi K**, Yamagata K**, Fujimoto S**, Tsuruya K**, Narita I**, Kasahara M**, Shibagaki Y**, Moriyama T**, Kondo M**, Iseki C**, Watanabe T**: Dipstick proteinuria and all-cause mortality among the general population. Clin Exp Nephrol. 2018; 22(6): 1331-1340 B

7) Kawasaki R**, Konta T, Nishida K**: Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database. Diabetes Obes Metab. 2018; 20(10): 2351-2360 B

8) Yamamoto R**, Imai E**, Maruyama S**, Yokoyama H**, Sugiyama H**, Nitta K**, Tsukamoto T**, Uchida S**, Takeda A**, Sato T**, Wada T**, Hayashi H**, Akai Y**, Fukunaga M**, Tsuruya K**, Masutani K**, Konta T, Shoji T**, Hiramatsu T**, Goto S**, Tamai H**, Nishio S**, Shirasaki A**, Nagai K**, Yamagata K**, Hasegawa H**, Yasuda H**, Ichida S**, Naruse T**, Fukami K**, Nishino T**, Sobajima H**, Tanaka S**, Akahori T**, Ito T**, Yoshio T**, Katafuchi R**, Fujimoto S**, Okada H**, Ishimura E**, Kazama JJ**, Hiromura K**, Mimura T**, Suzuki S**, Saka Y**, Sofue T**, Suzuki Y**, Shibagaki Y**, Kitagawa K**, Morozumi K**, Fujita Y**, Mizutani M**, Shigematsu T**, Kashihara N**, Sato H**, Matsuo S**, Narita I**, Isaka Y**: Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study. Clin Exp Nephrol. 2018; 22(6): 1266-1280 B

9) Honda Y*, Watanabe T*, Tamura H*, Nishiyama S*, Takahashi H*, Arimoto T*, Shishido T*, Miyamoto T*, Shibata Y*, Konta T, Kayama T*, Kubota I*: Presence of Myocardial Damage Predicts Future Development of Hypertension in a Normotensive Japanese General Population: The Yamagata (Takahata) Study. Am J Hypertens. 2018; 31(5): 549-556

10) Iseki K**, Konta T, Asahi K**, Yamagata K**, Fujimoto S**, Tsuruya K**, Narita I**, Kasahara M**, Shibagaki Y**, Moriyama T**, Kondo M**, Iseki C**, Watanabe T**; “Design of the Comprehensive Health Care System for Chronic Kidney Disease (CKD) Based on the Individual Risk Assessment by Specific Health Check”: Glucosuria and all-cause mortality among general screening participants. Clin Exp Nephrol. 2018; 22(4): 850-859 B

11) Iseki K**, Konta T, Asahi K**, Yamagata K**, Fujimoto S**, Tsuruya K**, Narita I**, Kasahara M**, Shibagaki Y**, Moriyama T**, Kondo M**, Iseki C**, Watanabe T**;‘Design of the Comprehensive Health Care System for Chronic Kidney Disease (CKD) Based on the Individual Risk Assessment by Specific Health Check’: Association of dipstick hematuria with all-cause mortality in the general population: results from the specific health check and guidance program in Japan. Nephrol Dial Transplant. 2018; 33(5): 825-832 B

12) Sato Y**, Fujimoto S**, Konta T, Iseki K**, Moriyama T**, Yamagata K**, Tsuruya K**, Narita I**, Kondo M**, Kasahara M**, Shibagaki Y**, Asahi K**, Watanabe T**: Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease. Clin Exp Nephrol. 2018; 22(2): 388-394 B

13) Kon S*, Konta T, Ichikawa K*, Asahi K*, Yamagata K**, Fujimoto S**, Tsuruya K**, Narita I**, Kasahara M**, Shibagaki Y**, Iseki K**, Moriyama T**, Kondo M**, Watanabe T**: Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan. Clin Exp Nephrol. 2018; 22(2): 346-352 B

14) Hirai H**, Asahi K**, Yamaguchi S**, Mori H**, Satoh H**, Iseki K**, Moriyama T**, Yamagata K**, Tsuruya K**, Fujimoto S**, Narita I**, Konta T, Kondo M**, Shibagaki Y**, Kasahara M**, Watanabe T**, Shimabukuro M**: New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population. Sci Rep. 2019; 9(1): 2813 B

15) Watanabe S*, Konta T, Ichikawa K*, Watanabe M*, Ishizawa K*, Ueno Y*, Yamashita H*, Kayama T*, Kubota I*: The association between urinary sodium excretion and blood pressure in a community-based population: the Yamagata (Takahata) study. Clin Exp Nephrol. 2019; 23(3): 380-386

16) Mori M**, Mochizuki K**, Souri M, Nakamura Y**, Tokuman N**, Kanouchi K*, Morikane K*, Ichinose A*: Complete remission in a bleeding patient with idiopathic autoimmune factor X deficiency caused by non-neutralizing anti-factor X autoantibody. Haemophilia. 2019; 25(2): e106-e109 B

17) Ogawa H**, Souri M, Kanouchi K*, Osaki T, Ohkubo R**, Kawanishi T**, Wakai S**, Morikane K*, Ichinose A*: A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis. Int J Hematol. 2019; 109(2):214-220 B

18) Nakamura K**, Uchida T**, Sho R, Hamasaki A*, Hayashi J*, Sadahiro M*: Analysis of risk factors for aortic enlargement in patients with chronic type B aortic dissection. Ann Vasc Dis. 2018; 11(4): 1-6 B

19) Hamada A*, Oizumi H*, Kato H*, Suzuki J*, Nakahashi K*, Sho R, Sadahiro M*: Learning curve for port access thoracoscopic anatomical lung segmentectomy. J Thorac Cardiovasc Surg. 2018; 156(5): 1995-2003

20) 中村健**, 内田徹郎**, 邵力, 浜崎安純*, 林潤*, 貞弘光章*: 慢性B型解離における大動脈血管径増大に関わる因子. 日本血管外科学会雑誌. 2018; 27: 55-60 B

21) 富永綾, 豊口禎子＊, 細谷順＊, 白石正＊, 今田恒夫: 抗菌薬のAntimicrobial Use DensityおよびDays of Therapyと耐性率の検討. 山形医学. 2019; 37(1): 8-18

(2) 総説及び解説

1) 今田恒夫: 急性腎障害・急性腎不全.臨床検査. 2018; 62(4): 464-465

2) 惣宇利正善: 先天性XIII因子欠乏症の診断と治療. 日本血栓止血学会誌. 2018; 29(6): 703-706

3) 惣宇利正善: 血液凝固第XIII因子の機能. Frontiers in Haemophilia. 2019; 6(1): 17-21

(3) 症例報告

1) 明石直樹, 小川孔幸, 柳澤邦雄, 大崎洋平, 清水啓明, 石埼卓馬, 井上まどか, 村上正巳, 惣宇利正善, 一瀬白帝, 半田寛: 初回寛解から４年後に再燃した後天性凝固第V因子インヒビター. 臨床血液. 2019; 60(1): 46-50

(4) 著書

1) 今田恒夫: CKDの診断と意義. 日本腎臓学会編, エビデンスに基づくCKD診療ガイドライン. 東京; 東京医学社, 2018: 1-8

2) 今田恒夫: 検査の基準値・基準範囲はどのようにして決まるか？深川雅史監修, 花房規男, 鶴屋和彦, 駒場大峰編, 透析患者の検査値の読み方第4版. 東京; 日本メディカルセンター, 2019: 19-20